UNLABELLED: Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin. AIM: Here, we tested if MC4R also contributes to leptin's effects on respiratory function. METHODS: After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT ), respiratory frequency (fR ) and pulmonary ventilation (VE ) were measured by whole-body plethysmography during normocapnia or hypercapnia (7% CO2 ). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE , VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin-cre) or only in proopiomelanocortin neurones (LepR/POMC-cre) and in MC4R knockout (MC4R(-/-) ) and wild-type mice. RESULTS: Leptin (5 μg day(-1) ) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day(-1) ) increased body weight (~18%) and reduced ventilatory responses compared with control-PBS group (Lep: 2119 ± 90 mL min(-1) kg(-1) and SHU9119: 997 ± 67 mL min(-1) kg(-1) , vs. PBS: 1379 ± 91 mL min(-1) kg(-1) ). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min(-1) kg(-1) ). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin-cre, LepR/POMC-cre and MC4R(-/-) mice. CONCLUSION: These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia.
UNLABELLED: Melanocortin receptors (MC3/4R) mediate most of the metabolic and cardiovascular actions of leptin. AIM: Here, we tested if MC4R also contributes to leptin's effects on respiratory function. METHODS: After control measurements, male Holtzman rats received daily microinjections of leptin, SHU9119 (MC3/4R antagonist) or SHU9119 combined with leptin infused into the brain lateral ventricle for 7 days. On the 6th day of treatment, tidal volume (VT ), respiratory frequency (fR ) and pulmonary ventilation (VE ) were measured by whole-body plethysmography during normocapnia or hypercapnia (7% CO2 ). Baseline mean arterial pressure (MAP), heart rate (HR) and metabolic rate were also measured. VE , VT and fR were also measured in mice with leptin receptor deletion in the entire central nervous system (LepR/Nestin-cre) or only in proopiomelanocortin neurones (LepR/POMC-cre) and in MC4R knockout (MC4R(-/-) ) and wild-type mice. RESULTS:Leptin (5 μg day(-1) ) reduced body weight (~17%) and increased ventilatory response to hypercapnia, whereas SHU9119 (0.6 nmol day(-1) ) increased body weight (~18%) and reduced ventilatory responses compared with control-PBS group (Lep: 2119 ± 90 mL min(-1) kg(-1) and SHU9119: 997 ± 67 mL min(-1) kg(-1) , vs. PBS: 1379 ± 91 mL min(-1) kg(-1) ). MAP increased after leptin treatment (130 ± 2 mmHg) compared to PBS (106 ± 3 mmHg) or SHU9119 alone (109 ± 3 mmHg). SHU9119 prevented the effects of leptin on body weight, MAP (102 ± 3 mmHg) and ventilatory response to hypercapnia (1391 ± 137 mL min(-1) kg(-1) ). The ventilatory response to hypercapnia was attenuated in the LepR/Nestin-cre, LepR/POMC-cre and MC4R(-/-) mice. CONCLUSION: These results suggest that central MC4R mediate the effects of leptin on respiratory response to hypercapnia.
Authors: John E Hall; Alexandre A da Silva; Jussara M do Carmo; John Dubinion; Shereen Hamza; Shankar Munusamy; Grant Smith; David E Stec Journal: J Biol Chem Date: 2010-03-26 Impact factor: 5.157
Authors: Markus Fendt; Hugo Bürki; Stefan Imobersteg; Kurt Lingenhöhl; Kevin H McAllister; David Orain; Doncho P Uzunov; Frederique Chaperon Journal: Psychopharmacology (Berl) Date: 2009-07-17 Impact factor: 4.530
Authors: Allyn L Mark; Khristofor Agassandian; Donald A Morgan; Xuebo Liu; Martin D Cassell; Kamal Rahmouni Journal: Hypertension Date: 2008-12-22 Impact factor: 10.190
Authors: Alexandre A da Silva; Jussara M do Carmo; J Nathan Freeman; Lakshmi S Tallam; John E Hall Journal: Diabetes Date: 2009-06-02 Impact factor: 9.461
Authors: M Bassi; W I Furuya; D B Zoccal; J V Menani; E Colombari; J E Hall; A A da Silva; J M do Carmo; D S A Colombari Journal: Life Sci Date: 2015-01-30 Impact factor: 5.037
Authors: Jussara M do Carmo; Alexandre A da Silva; Sydney P Moak; Fernanda S da Silva; Frank T Spradley; John E Hall Journal: Acta Physiol (Oxf) Date: 2018-12-23 Impact factor: 6.311
Authors: J M Witkin; R Cerne; P G Davis; K B Freeman; J M do Carmo; J K Rowlett; K R Methuku; A Okun; S D Gleason; X Li; M J Krambis; M Poe; G Li; J M Schkeryantz; R Jahan; L Yang; W Guo; L K Golani; W H Anderson; J T Catlow; T M Jones; F Porreca; J L Smith; K L Knopp; J M Cook Journal: Pharmacol Biochem Behav Date: 2019-02-27 Impact factor: 3.533
Authors: M Bassi; W I Furuya; D B Zoccal; J V Menani; D S A Colombari; D K Mulkey; E Colombari Journal: J Physiol Date: 2015-06-22 Impact factor: 5.182
Authors: E Andrew Townsend; Jennifer E Naylor; S Stevens Negus; Shelley R Edwards; Hina N Qureshi; Hunter W McLendon; Christopher R McCurdy; Coco N Kapanda; Jussara M do Carmo; Fernanda S da Silva; John E Hall; Kenneth J Sufka; Kevin B Freeman Journal: Psychopharmacology (Berl) Date: 2017-05-31 Impact factor: 4.530
Authors: Qiaoling Yao; Huy Pho; Jason Kirkness; Ellen E Ladenheim; Sheng Bi; Timothy H Moran; David D Fuller; Alan R Schwartz; Vsevolod Y Polotsky Journal: Sleep Date: 2016-05-01 Impact factor: 5.849
Authors: Slava Berger; Huy Pho; Thomaz Fleury-Curado; Shannon Bevans-Fonti; Haris Younas; Mi-Kyung Shin; Jonathan C Jun; Frederick Anokye-Danso; Rexford S Ahima; Lynn W Enquist; David Mendelowitz; Alan R Schwartz; Vsevolod Y Polotsky Journal: Am J Respir Crit Care Med Date: 2019-03-15 Impact factor: 21.405
Authors: Guilherme F Speretta; Eduardo Vieira Lemes; Regina C Vendramini; José V Menani; Daniel B Zoccal; Eduardo Colombari; Débora S A Colombari; Mirian Bassi Journal: Respir Physiol Neurobiol Date: 2018-10-09 Impact factor: 1.931